Skip to content

Samba Reddy appointed editor of Experimental Neurology

Pioneering neurotherapeutics expert takes the helm as editor of the peer-reviewed journal Experimental Neurology
Dr. Samba Reddy

Samba Reddy, PhD, RPh, Regents Professor in the Department of Neuroscience and Experimental Therapeutics and director of the Institute of Pharmacology and Neurotherapeutics at Texas A&M University School of Medicine, has been appointed the editor of Experimental Neurology, a prestigious monthly peer-reviewed medical journal.

Experimental Neurology, renowned for its focus on neuroscience research on the mechanisms underlying neurological disorders, is considered a top-level journal in the field, boasting an impressive impact factor of 5.6. The journal’s scope encompasses a wide range of topics, including neural development, neuroregeneration, neuroplasticity and transplantation, making it a pivotal platform for disseminating cutting-edge research in neurology and neuroscience.

With more than two decades of experience in academia and research, Reddy has established himself as a global leader in neurotherapeutics, particularly in developing new treatments for epilepsy and other brain disorders affecting millions worldwide.

A Chancellor EDGES Fellow and a board-certified pharmacist, Reddy’s research endeavors have been consistently funded by prestigious institutions such as the National Institutes of Health (NIH) and the U.S. Department of Defense (DOD), with annual grant funding exceeding $1.6 million. His work has led to the development of novel neurosteroid treatments for seizures and nerve agent neurotoxicity, as well as the FDA approval of groundbreaking medicines such as Brexanolone for post-partum depression and ganaxolone for seizures in CDKL5-deficiency epilepsy.

In addition to his remarkable research achievements, Reddy is a dedicated educator, teaching medical and graduate-level courses and mentoring numerous students and postdoctoral scholars. His commitment to advancing the field of neuroscience is further evidenced by his service on various national panels and organizations, including the National Institutes of Health, DOD and US Pharmacopoeia.

Reddy’s appointment as editor of Experimental Neurology is a testament to his unwavering dedication to advancing scientific knowledge and improving health care outcomes for individuals suffering from neurological disorders. Under his editorial leadership, Experimental Neurology is poised to continue its tradition of excellence in publishing groundbreaking research that shapes the future of neurology and neuroscience.

Media contact:

Share This

Related Posts

Back To Top